MADI Inc. is a digital health startup revolutionizing clinical trials through AI-powered digital twins. Founded by medical professors and AI experts in 2025, MADI-DT creates synthetic patients using generative AI trained on Asian cohort data, serving as virtual control groups. This innovation reduces trial costs by $2.3M, accelerates time